NCT07348419 Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery
| NCT ID | NCT07348419 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsun University |
| Condition | Acute Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-01-06 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-01-06 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to compare the postoperative analgesic efficacy of the classical thoracolumbar interfascial plane block and the Quadro-iliac plane block for postoperative analgesia management after lumbar disc surgery.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-70 years, * Classified as ASA physical status I-III, * Scheduled to undergo single-level lumbar spinal surgery under general anesthesia * Who agree to participate in the study by providing written informed consent Exclusion Criteria: * History of bleeding diathesis or current anticoagulant therapy * Known allergy or hypersensitivity to local anesthetics or opioid medications * Infection at the planned block injection site * Previous lumbar spine surgery * History of gabapentinoid or corticosteroid use within the last 3 weeks * Inability to use a patient-controlled analgesia (PCA) device * Suspected pregnancy, confirmed pregnancy, or breastfeeding * Refusal to undergo the procedure or to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07348419 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Acute Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07348419 currently recruiting?
Yes, NCT07348419 is actively recruiting participants. Contact the research team at ck_hale@hotmail.com for enrollment information.
Where is the NCT07348419 trial being conducted?
This trial is being conducted at Samsun, Turkey (Türkiye).
Who is sponsoring the NCT07348419 clinical trial?
NCT07348419 is sponsored by Samsun University. The trial plans to enroll 70 participants.